SHAREHOLDERS' EQUITY (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Jul. 24, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average basic common shares (in shares)	13,100,000	12,846,000
Effect of stock options (in shares)	61,000	54,000
Effect of dilutive share awards (in shares)	115,000	35,000
Weighted average diluted common shares (in shares)	13,276,000	12,935,000
Common stock repurchases
Purchased shares of common stock under stock repurchase program (in shares)	0	0
Remaining authorized repurchase amount	$ 96.7
2025 Convertible Notes
Additional disclosure
Stated interest rate	0.50%
2025 Convertible Notes | Convertible Debt
Additional disclosure
Stated interest rate	0.50%		0.50%
Option
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	1,000,000	1,000,000
Restricted Stock Units (RSUs)
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	300,000	400,000
Convertible Debt
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	600,000	1,200,000